Introduction to GMO and pharmaceuticals

The issue of GMO foods polarises opinion between those who see it as the only viable solution to feed a growing global population and those who fear inadequate testing of the technology will lead to dire consequences if implemented without sufficient safeguards. There is an absence of transparency in the testing of GM since regulatory oversight was captured by industry leaders such as Monsanto in the 1980s under Ronald Reagan. Critical Thinking will be assessing the evidence and incentives to suppress data which would prejudice the commercial interests of the GM companies.

The rewards for shareholders and executives of big pharmaceutical companies depend on bringing "blockbuster prescription drugs" to market. They use aggressive marketing techniques to persuade doctors to prescribe their drugs and are financially motivated to sell more and more drugs rather than improve health. We will be exploring these issues and studying the evidence.